Mechanism of EGR2 in Allergic Rhinitis | Clinical Trial | StuddyBuddy@endsection Mechanism of EGR2 in Allergic Rhinitis
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT05724290

Mechanism of EGR2 in Allergic Rhinitis

Conditions: Rhinitis, Allergic

Sex: All
Ages: 16 Years – 76 Years
Phase: PHASE1
Enrollment: 3
Sponsor: Zu-xia Ma

Location: China

Summary

EGR2 may be a target for the treatment of nasal polyps.

Eligibility Criteria

Inclusion Criteria:All patients were stopped by systemic or topical corticosteroid treatment at least one month before the study.Exclusion Criteria:Patients had NPs accompanied by choanal polyps, fungal nasal sinusitis, cystic fibrosis, acute upper airway upper infection or other systemic diseases.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05724290). StuddyBuddy aggregates publicly available trial information.